| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/19/2004 | WO2004070029A1 Method to encode a dna sequence and to compress a dna sequence |
| 08/19/2004 | WO2004070027A2 Method for modifying plant growth characteristics |
| 08/19/2004 | WO2004070022A2 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 08/19/2004 | WO2004070020A2 Glyphosate tolerant alfalfa events and methods for detection thereof |
| 08/19/2004 | WO2004070019A2 Membrane active polymers |
| 08/19/2004 | WO2004070018A2 Vegf-b and pdgf modulation of stem cells |
| 08/19/2004 | WO2004070016A2 System for expression of genes in plants |
| 08/19/2004 | WO2004070015A2 Nematode pan and zp receptor-like sequences |
| 08/19/2004 | WO2004070008A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | WO2004070007A2 Method for preparing single-stranded dna libraries |
| 08/19/2004 | WO2004070006A2 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | WO2004070005A2 Double ended sequencing |
| 08/19/2004 | WO2004070004A2 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | WO2004070003A2 Methods for selecting and screening for trasformants |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069997A2 Method for the production of a composition of dna sequences or the expression products thereof permitting the identification of the strains of helicobacter pylori and use thereof in a prognostic or diagnostic method |
| 08/19/2004 | WO2004069996A2 Bacteria and process for producing chemical compounds by said bacteria |
| 08/19/2004 | WO2004069995A2 Transposon-based targeting system |
| 08/19/2004 | WO2004069994A2 Transposon-based targeting system |
| 08/19/2004 | WO2004069993A2 Non-touch zona pellucida microdrilling of a single - cell embryo with a 1.48 um laser beam for introduction of retrovirus |
| 08/19/2004 | WO2004069992A2 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | WO2004069991A2 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | WO2004069990A2 Oligomeric compounds for the modulation of thioredoxin expression |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069875A2 Immunoglobulin anti integrin |
| 08/19/2004 | WO2004069870A2 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069868A1 Complex of telomere protein with guanine-quadruplex dna |
| 08/19/2004 | WO2004069865A2 Control of plant growth and developmental processes |
| 08/19/2004 | WO2004069864A1 Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 08/19/2004 | WO2004069858A2 Leukocyte stimulating peptides |
| 08/19/2004 | WO2004069850A2 Switchable nucleic acids for diagnostics, screening and molecular electronics |
| 08/19/2004 | WO2004069849A2 Bead emulsion nucleic acid amplification |
| 08/19/2004 | WO2004069406A1 Novel supported catalyst systems |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |
| 08/19/2004 | WO2004069204A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069182A2 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | WO2004069176A2 Polymer conjugates of mutated neublastin |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069148A2 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids |
| 08/19/2004 | WO2004069140A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 08/19/2004 | WO2004068931A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | WO2004061408A3 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 08/19/2004 | WO2004060390A3 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 08/19/2004 | WO2004058821A3 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 08/19/2004 | WO2004056986A3 Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors |
| 08/19/2004 | WO2004050829A3 Recombinant double-stranded rna phage, and use of the same |
| 08/19/2004 | WO2004047770A3 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 08/19/2004 | WO2004042066A3 NtSM GENE |
| 08/19/2004 | WO2004042058A3 Novel buffer formulations for isolating, purifying and recovering long-chain and short-chain nucleic acids |
| 08/19/2004 | WO2004040018A3 Qualitative differential screening for the detection of rna splice sites |
| 08/19/2004 | WO2004039985B1 Selective expression in filamentous fungi |
| 08/19/2004 | WO2004038019A3 Dnazyme cleaving mutant polynucleotides |
| 08/19/2004 | WO2004031234A3 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 08/19/2004 | WO2004031222A3 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 08/19/2004 | WO2004027067A3 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 08/19/2004 | WO2004026227A3 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 08/19/2004 | WO2004024940A3 Rna-mediated gene modulation |
| 08/19/2004 | WO2004024917A3 Single-molecule in vitro evolution |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004016805A9 Immunostimulatory nucleic acids |
| 08/19/2004 | WO2004016651A3 Spider silk polypeptide |
| 08/19/2004 | WO2004016215A3 Use of antisense oligonucleotides to inhibit the expression of akt-1 |
| 08/19/2004 | WO2004011614A3 Virus induced gene silencing in plants |
| 08/19/2004 | WO2004005480A3 Plastid genetic engineering via somatic embryogenesis |
| 08/19/2004 | WO2004003509A3 A method to identify specific interaction between ligand and receptor |
| 08/19/2004 | WO2004003136A3 Methods of detecting sequence differences |
| 08/19/2004 | WO2004001371A3 Receptor capture assay |
| 08/19/2004 | WO2003095663A3 Modified t lymphocytes and uses therefor |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003083086A3 High level expression of immunogenic proteins in the plastids of higher plants |
| 08/19/2004 | WO2003072750A3 Expression of hiv-related proteins in plants |
| 08/19/2004 | WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/19/2004 | WO2003066880A3 Method for accessing microbial diversity |
| 08/19/2004 | WO2003064667A8 Process for the reversible functional inactivation of the mismatch repair system |
| 08/19/2004 | WO2003060084A3 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003040694A3 Enzymatic cycling assays for homocysteine and cystathionine |
| 08/19/2004 | WO2003040320A3 Antisense modulation of human collapsin response mediator protein 2 expression |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | WO2003037260A3 Methods and compositions for treating parkinson's disease |
| 08/19/2004 | WO2003025149A8 Cell populations which co-express cd49c and cd90 |
| 08/19/2004 | WO2003001876A8 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/19/2004 | US20040163147 Nucleic acid sequences comprising pericentric heterochromatic region of a chromosome and nucleotide sequences which confer disease resistance to plants for use in generation of satellite DNA based artificial chromosomes |
| 08/19/2004 | US20040163146 Vascular-preferred promoters |
| 08/19/2004 | US20040163145 Vector/recombinase transformation/insertion in organelles; heterologous gene expression; bioreactors |
| 08/19/2004 | US20040163144 Maize embryo-specific promoter compositions and methods for use thereof |
| 08/19/2004 | US20040163143 Method for efficiently producing transgenic plant using auxin precursor |
| 08/19/2004 | US20040163142 Methods and composition for modulating flavonoid content |
| 08/19/2004 | US20040163141 Genetic manipulation of spermatogonia |
| 08/19/2004 | US20040163140 Biological material |
| 08/19/2004 | US20040163137 PG-3 and biallelic markers thereof |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162420 Comprises expression vector coding nucleic acid sequences in reverse orientation for use in generating transgenic tobacco plants with reduced nicotine concentration; gene expression inhibition |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040162416 Expression vector for use in transformation and propagation of heterologous nucleotide sequences in eucaryotic cells; bioreactors |
| 08/19/2004 | US20040162260 Drug delivery; to decrease cellular toxicity and improve efficacy |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162255 To deliver specifically tailored small interfering RNA as therapeutic agents for treatment of Parkinson's disease |